Erukainure_2021_Endocr.Metab.Immune.Disord.Drug.Targets_21_688

Reference

Title : Cola Nitida (Kola Nuts) Attenuates Hepatic Injury in Type 2 Diabetes by Improving Antioxidant and Cholinergic Dysfunctions and Dysregulated Lipid Metabolism - Erukainure_2021_Endocr.Metab.Immune.Disord.Drug.Targets_21_688
Author(s) : Erukainure OL , Sanni O , Salau VF , Koorbanally NA , Islam MS
Ref : Endocr Metab Immune Disord Drug Targets , 21 :688 , 2021
Abstract : Erukainure_2021_Endocr.Metab.Immune.Disord.Drug.Targets_21_688
ESTHER : Erukainure_2021_Endocr.Metab.Immune.Disord.Drug.Targets_21_688
PubMedSearch : Erukainure_2021_Endocr.Metab.Immune.Disord.Drug.Targets_21_688
PubMedID: 32600241

Related information

Citations formats

Erukainure OL, Sanni O, Salau VF, Koorbanally NA, Islam MS (2021)
Cola Nitida (Kola Nuts) Attenuates Hepatic Injury in Type 2 Diabetes by Improving Antioxidant and Cholinergic Dysfunctions and Dysregulated Lipid Metabolism
Endocr Metab Immune Disord Drug Targets 21 :688

Erukainure OL, Sanni O, Salau VF, Koorbanally NA, Islam MS (2021)
Endocr Metab Immune Disord Drug Targets 21 :688